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Abstract
The interest in the extracellular vesicles (EVs)
is rapidly growing as they became reliable
biomarkers for many diseases. For this reason,
fast and accurate techniques of EVs size char-
acterization are the matter of utmost impor-
tance. One increasingly popular technique is
the Nanoparticle Tracking Analysis (NTA), in
which the diameters of EVs are calculated from
their diffusion constants. The crucial assump-
tion here is that the diffusion in NTA follows
the Stokes-Einstein relation, i.e. that the Mean
Square Displacement (MSD) of a particle grows
linearly in time (MSD ∝ t). However, we show
that NTA violates this assumption in both arti-
ficial and biological samples, i.e. a large popu-
lation of particles show a strongly sub-diffusive
behaviour (MSD ∝ tα, 0 < α < 1). To sup-
port this observation we present a range of ex-
perimental results for both polystyrene beads
and EVs. This is also related to another prob-
lem: for the same samples there exists a huge
discrepancy (by the factor of 2-4) between the
sizes measured with NTA and with the direct
imaging methods, such as AFM. This can be
remedied by e.g. the Finite Track Length Ad-
justment (FTLA) method in NTA, but its ap-
plicability is limited in the biological and poly-
disperse samples. On the other hand, the mod-
els of sub-diffusion rarely provide the direct re-
lation between the size of a particle and the gen-
eralized diffusion constant. However, we solve
this last problem by introducing the logarith-
mic model of sub-diffusion, aimed at retrieving
the size data. In result, we propose a novel
protocol of NTA data analysis. The accuracy
of our method is on par with FTLA for small
('200nm) particles. We apply our method to
study the EVs samples and corroborate the re-
sults with AFM. Incorporating the sub-diffusive
effects reduces the average measured EV diam-
eter by '50% in comparison to the normal dif-
fusion models. The remaining discrepancy be-
tween NTA and AFM can be explained with
several known effects, which we also discuss in
this article.
Introduction
Extracellular microvesicles (EVs) are the frag-
ments of cell membranes generated by both
prokaryotic and eukaryotic cells.1 EVs diame-
ter varies between 50 and 1000nm.2 Their pres-
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ence was firstly reported using hemocytometry
methods in late 60’s and suggested a proco-
agulant potential.3 Neglected for the next 20
years, EVs drew back the scientists’ attention
in late 90s, as possible thrombotic activators.4
Microscopically, they consist of cell components
including a lipid bilayer, cytoplasm and ribo-
somal fragments.5 It has been commonly ac-
cepted that EVs can be produced either by
budding the cell membrane fragments (ecto-
somes), or by the subsequent exocytosis.2,6,7
In blood, the main source of EVs are platelets
and endothelial cells. Nevertheless, in stress-
ing conditions (hypoxia, inflammation or hyper-
glycemia), also macrophages and neutrophils
can release a number of EVs.8,9 The rapidly
growing interest in EVs has a significant im-
pact on the clinical and basic science, provid-
ing the novel potential for nanomedicine with
new biomarkers, therapeutic targets and cell-
to-cell communication vehicles.10 The majority
of clinical data, obtained from the flow cytom-
etry studies, show the heterogeneousness of EV
surface antigen profile.1,4,8,9 However, the sig-
nificant progress in nanotechnology has recently
allowed a systemic approach to isolation, enu-
meration and the characterization of EVs size,
shape and molecular components.11,12
Present research has demonstrated that, the
larger population of EVs - ectosomes - rep-
resents a rather heterogeneous population of
vesicles whose size ranges from 100 to 1000
nm in diameter.11,13 Their size distribution
can be determined with a range of meth-
ods, e.g.: scanning and transmission electron
microscopy (EM),5,8,14 tunable resistive pulse
sensing (TRPS),15–17 atomic force microscopy
(AFM)18 and nanoparticle tracking analysis
(NTA).19,20 Fig. 1 illustrates their application
to EVs studies.
NTA is of particular interest in this article,
as it is involved in 58% of the current EVs-
related research.21 In this technique a sample
of a biological fluid is observed through a mi-
croscope. A laser beam illuminates the sample
from the direction perpendicular to the optical
axis. The particles diffusing in the plane of the
laser beam are visible thanks to the scattered
light and their trajectories can be recorded (Fig.
Figure 1: Extracellular vesicles visualization
methods. (A) Image showing typical tracks of
EVs moving under Brownian motion recorded
by means of the NTA method. (B,C) Transmis-
sion Electron Microscopy (TEM) images of EVs
isolated from human plasma using the ultra-
centifugation method. Samples were fixed with
2.5% glutaraldehyde in 0.1M cacodylic buffer
and then postfixed in 1% osmium tetroxide so-
lution. (D) Topography of EVs placed on a poli-
L-lysine coated slide. Samples were analysed
by means of Atomic Force Microscopy (AFM).
The yellow line shows the cross-section, the col-
orimetric scale indicates the Z dimension pre-
sented as a height profile across the section line
(E).
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1A). However, the size of the particles is not
concluded from the direct observation (which is
constrained by the diffraction limit), but from
the estimation of their diffusion constant. In
the simplest approach, for each trajectory the
mean square displacement (MSD) can be cal-
culated and the Stokes-Einstein theory of diffu-
sion predicts that MSD grows linearly in time,
i.e.:
MSD(t) = 2D1t D1 =
kBT
3piη0d
(1)
where  is dimensionality ( = 2 for NTA), kB is
the Boltzmann constant, T is temperature, η0 is
the viscosity of a sample and d is the diameter
of a particle. Equation (1) relates the diameter
d of a particle to the diffusion constant D1 and
makes it possible to find the diameter distribu-
tion from the set of trajectories. The diffusion
described by the relation (1) is called normal.
NTA has entered the field of EVs research rel-
atively recently and the evaluation of its appli-
cability to biological samples is still in progress.
Most comparative studies involving NTA fo-
cuses on its advantages over e.g. flow cytom-
etry and dynamic light scattering (DLS).12,18,19
NTA also proves to be competitive against
AFM or EM, as it is cheap, fast and does
not require much additional preparation of the
sample that could affect the biological state of
EVs.12,18 Thus, it is looked at as a ’method-
of-choice’ in the EVs characterization with a
possibly broad use in the future diagnostics.
However, few studies examine whether the as-
sumptions of NTA are satisfied in the biological
context. In particular, the presence of normal
diffusion is usually taken for granted.
In this article we show that the assumption
of normal diffusion is neither true in the bio-
logical samples nor, more surprisingly, for ar-
tificial mono-disperse beads. In all cases a re-
markably huge population of particles has the
MSD that grows sub-linearly in time. This is a
strong signature of sub-diffusion. We obtained
these results consistently in several different ex-
periments involving EVs from human plasma
and artificial beads. Measurements were per-
formed on two different NanoSight NTA ana-
lyzers (Malvern Instruments) in two separate
institutes, which make us believe that the issue
is inherent at least to this popular producer.
Thus, the main goal of this paper is to propose
the new procedure of NTA data analysis that
accounts for the sub-diffusive effects.
The claim that the fundamental assumption
of NTA, i.e. the relation (1), is not satisfied,
might be surprising, as the NanoSight performs
well in the industrial applications. The rea-
son is that, by default, the NanoSight soft-
ware applies the finite track length adjustment
(FTLA)22,23 algorithm to the data. The actual
implementation of FTLA in this software is not
specified, but much can be inferred from the
underlying study by Savney et al.22 The pro-
cedure assumes that the observed distribution
of sizes is the convolution of the ideal size dis-
tribution and the broadening effects from the
finite length of recorded tracks. The parame-
ters of the ideal distribution are fitted via the
maximum likelihood method and this ideal dis-
tribution is provided as the final result. Two
sets of assumptions are involved here. One is
the form of the ideal distribution itself. For
a mono-disperse sample it is expected to be a
mono-peaked function. However, when the un-
known number of different-sized species is in-
volved, one cannot predict how many peaks are
necessary. Indeed, FTLA performance exacer-
bates in the poly-disperse model systems.31 The
other assumption is that the broadening effects
follow from the normal diffusion model. As this
is not satisfied, the corrections are only a crude
approximation for these effects. Nevertheless,
FTLA significantly improves the results for the
mono-disperse model systems. However, its in-
fluence on the much more complex EVs samples
is uncontrolled and, in fact, it was reported to
cause artefacts.12 For these reasons a more di-
rect method is desirable.
There is also another problem related to the
biological applications of NTA. When the same
sample is simultaneously measured with the di-
rect imaging methods (e.g. AFM or EM) and
NTA, NTA turns out to significantly overesti-
mate the average size. This discrepancy is ob-
served in the study of EVs,24,25 but also for the
coated gold nano-particles26 and, to a minor ex-
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tend, model polystyrene beads.20 Our own mea-
surements of EVs from human plasma, which
we discuss further in this article, indicate that
the difference between AFM and NTA can be
of a factor 3-4 for normal diffusion models and
about 2 for FTLA.
A few effects contributing to this difference
are already recognized. One important reason
is that NTA has low sensitivity to the small
EVs (d < 50nm), which cuts out the low-end
of the size distribution.18,24 In our AFM study,
excluding all the particles smaller than 50nm in-
creases the mean EV diameter by roughly 34%-
40% (see Table 2). Another contribution comes
from the fact that NTA measures the hydrody-
namic radius, which might appear larger than
the inelastic core measured in AFM and EM.
This discrepancy is well-documented for the la-
tex and polystyrene beads in monodisperse so-
lutions, studied by both NTA and DLS.27–29
However, to see this effect in AFM one must
usually reduce the widening due to the tip con-
volution effect (algorithmically or by using a
properly sharp tip),30 as it might easily domi-
nate the results. In general, the hydrodynamic
widening overestimates the size by 50% for very
small particles (d ' 16nm),27,29 by 30% for
d ' 50nm, by 5-20% for 100nm particles27–29
and for d > 400nm the effect is negligible.27
There are few systematic studies on this effect
in the polydisperse systems, but from the work
of Filipe et al. one can conclude that the dif-
ference does not exceed 30%.27 Finally, NTA is
influenced by the lengths of recorder trajecto-
ries, e.g. the 100nm particles can be measured
as 15-25% larger when the extremely short (less
than 5 points) trajectories are used.31 On the
other hand, the binding to a surface and tip-
induced deformation might increase the appar-
ent size of EVs in AFM. For a sphere with radius
rs which is flatten into the disc with radius rd,
but conserves its area (so 4pir2s = 2pir2d), rs is at
worst 30% smaller than rd. The deformations
can be minimized by applying the ’tapping’ or
’non-contact’ mode in AFM. Summarizing all
of these effects, the size of particles measured
in NTA should be roughly 1.5-2.5 times larger
than the one resulting from AFM. Therefore,
the sub-diffusive model for NTA should predict
the EV size that fits into this range.
The NTA measurements are based on the ob-
servation of the diffusive motion, which might
be affected by a plethora of effects. For both
mono- and poly-disperse samples these factors
are e.g. confinement, molecular crowding, in-
homogeneous distribution of particles and in-
teractions between particles (electrostatic, hy-
drodynamic etc.). Poly-dispersity additionally
introduces the unspecific excluded volume in-
teractions32,33 and EVs might also bind bio-
chemically with other EVs and proteins.9,34 All
of these aspects violate the assumptions of the
Stokes-Einstein theory35–37 (1), which describes
the freely diffusing particle in an uncorrelated,
molecularly homogeneous environment. An-
other issue might be the design of the NTA
instrument itself, e.g. it might induce tempera-
ture gradients, counter-sedimentation flows and
the field of view might be distorted. In what
follows, the experimentally measured MSDs can
deviate significantly from the linear dependence
MSD ∝ t. This can be seen in Fig. 2A, where
we show MSD(t) for three exemplary trajecto-
ries from our measurements. For the short-to-
intermediate time MSD(t) resembles the free
diffusion behavior, but the slope of the data
on the log-log plot is clearly sub-linear, i.e.
MSD(t) ∝ tα, where 0 < α < 1. This is charac-
teristic for the sub-diffusion. From Fig. 2A one
can see that fitting the normal diffusion model,
i.e. MSD(t) = 2D1t + C2 (where C2 accounts
for the localization noise, see Berglund38), to
the sub-diffusive data leads to an underesti-
mated D1 and, in result, an overestimated d.
The free-diffusion regime is usually culminated
with a local maximum, after which MSD(t) de-
creases and fluctuates strongly. This behaviour
usually indicates that the boundary effects be-
come dominant.
The sub-diffusion (or, more generally, anoma-
lous diffusion) is a phenomenon ubiquitously
observed in the biological systems,39–43 which
gains more and more recognition in the bio-
and life- sciences.44 This is particularly impor-
tant since the sub-diffusion affects the efficiency
of transport in the molecularly crowded envi-
ronment, especially cytoplasm.39–41 Microscop-
ically, sub-diffusion is usually caused by the
4
Figure 2: A: MSD(t) plots for three exemplary
EVs trajectories, representing normal diffusion
(blue circles), intermediate sub-diffusion (green
squares) and strong sub-diffusion (red trian-
gles). The vertical lines show the cut-off time
taken into analysis. The data are fitted with the
linear model (8) (short-dashed lines), power-
law model (9) (dashed lines) and logarithmic
model (10) (solid lines). For a well pronounced
sub-diffusion the linear model clearly deviates
from the data (red and green plots), leading to
the underestimation of diffusion constant. B:
The mean position increment < ∆x(t) > and
< ∆y(t) > for each trajectory from panel B,
showing the influence of drift. The increments
are fitted with the power-law model ∝ tγ to test
for linearity.
geometrical confinement, trapping events that
intervene with the normal diffusion or by the
highly inhomogeneous viscosity of a system.39
The mathematical models of sub-diffusion are
numerous.35–37,45–48 In particular, three classes
stand out, i.e. Fractional Brownian Motion,48
Continuous Time Random Walks47 and Scaled
Brownian Motion.49–51 The former two are ca-
pable of ergodicity breaking,51–54 which can be
examined in the single particle tracking experi-
ments. However, most of these models are pre-
occupied with obtaining the anomalous expo-
nent α, i.e. reproducing the asymptotic depen-
dence:
MSD(t) = 2Dαtα (2)
where the generalized diffusion constant Dα is
usually assumed as a fitable parameter. Al-
though (2) and (1) seem deceptively similar,
they cannot be applied in the same manner.
While D1 is straightforwardly related to η0 and
d, there is no such simple dependence for Dα.
This can be seen from the dimensional analy-
sis, i.e. the units of D1 and Dα are m2/s and
m2/sα, respectively. Thus, one might interpret
that there is an additional time scale τ involved
in the sub-diffusion, such that Dα = D1/τα−1.
However, τ and D1 cannot be simultaneously
determined from the experimental data via sim-
ple fitting, i.e. if one fits MSD with D1tα/τα−1
model, it results in any pair of D1 and τ that
can be recombined intoDα corresponding to the
direct fitting of model (2). In what follows, it is
also not possible to measure the distribution of
diameters d with the aid of the model (2). Nev-
ertheless, since α is a very convenient measure
of anomalousness, we will frequently resort to
it. However, for the purpose of application in
NTA we must consider an alternative approach.
It should be emphasized that while the power-
law model (2) is a popular description of sub-
diffusion, it is mainly phenomenological. In
fact, sub-diffusion is always a composition of
multiple microscopic processes, as indicated by
the Mori-Zwanzig type models48 or by the inge-
nious visco-elastic approach, proposed by Goy-
chuk.46 Thus, different models of similar behav-
ior can be justified on this basis. To remedy
the problem of physical interpretation for Dα,
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we first attempted to use the modified power-
law model: MSD(t) = 2D1t/(1 + tτ )
1−α, which
asymptotically (t 0) behaves like (2) and sep-
arates D1 and τ . However, fitting this model to
MSD data did not result in the stable values of
D1 and τ , similarly as in the case of (2). Most
probably this is because NTA do not provide
enough information on the t → 0 behavior, for
which these two models mainly differ.
Our solution is provided by the logarithmic
model, based on the following, qualitative rea-
soning. In the dispersed colloidal solution there
is a certain average distance between particles.
At the short time scale, a particle diffuses freely,
but over a longer period, as
√
MSD(t) becomes
comparable to this average length-scale, a par-
ticle is more likely to encounter obstacles (i.e.
other particles). Thus, the viscosity of a system
’perceived’ by this particle effectively grows in
time. This can also happen if the particles are
systematically carried by a drift into the denser
region (i.e. near a barrier). In order to account
for these effects, we introduce the time depen-
dent viscosity η(t). In the lowest order, it can
be approximated as η(t) ' (1 + vt)η0, where v
is some effective speed of viscosity change. As-
suming that the short-time diffusion is still nor-
mal, the increment of MSD over some dt reads:
dMSD(t) =
2kT
3piη(t)d
dt ' 2D1
1 + vt
dt (3)
One can integrate this expression over time, to
obtain:
MSD(t) =
∫ t
0
ds
2D1
1 + vs
=
2D1
v
ln(1 + vt) (4)
The logarithmic model can mimic the power-
law behavior over several orders of magnitude,
when tuned properly. In fact, it can be seen as
an example of the ultra-slow scaled Brownian
motion49,50 and a similar result is encountered
in e.g. the granular gas.51 This model preserves
the standard interpretation of D1 and it keeps
D1 and v separated enough to allow reliable and
repetitive MSD fits. One might also check that
in this model limt→0 MSD(t)/t = 2D1, so it
predicts the non-zero diffusivity for every t, as
desired. It also leads to the normal diffusion for
v = 0, i.e. limv→0 MSD(t) = 2D1t. The qual-
ity of fits provided by this model is comparable
to the power-law model.
Samples and measurements
For the purpose of this work we gathered the
MSD data from NTA for the polystyrene (PS)
beads with diameters 203 and 453 nm (Thermo
Scientific) and EVs extracted from blood sam-
ples. Two series of experiments were carried
out: one, involving EVs and PS beads, at
the Institute of High Pressure Physics (Polish
Academy of Science, Warsaw) and the other,
involving only PS beads, but at several concen-
trations, at the Jerzy Haber Institute of Catal-
ysis and Surface Chemistry (Polish Academy of
Science, Krakow). The measurements were per-
formed by two different teams and involved two
different NTA instruments.
PSK: NTA measurements of PS beads
in Krakow. The 1% aqua solution of the
203 nm PS beads (Thermo Scientific) was di-
luted 103 and 104 times. The 1% solution of
453 nm PS beads was diluted 103, 2 × 103
and 5 × 103 times. For each concentration
and size the NTA measurements were repeated
three times. For 103 dilution runs lasted 25s
and 60s for the others. The experiments were
performed with NanoSight NS500 instrument
(Malvern Instruments Ltd. United Kingdom)
equipped with 405 nm laser, at a room temper-
ature of 20 − 24◦C (varying between measure-
ments). The shutter and gain were adjusted
manually. The NTA 3.2 (dev build 3.2.16) soft-
ware was used for capturing the data as well as
the preliminary and FTLA analysis.
PSW : NTA measurements of PS beads
in Warsaw. The 1% solutions of 203 nm and
453 nm polystyrene beads (Thermo Scientific)
were diluted 7× 103 and 5× 103 times, respec-
tively. The NTA measurement lasted 90 s for
bigger particles and 60 s for the smaller, each
run was repeated three times. The temperature
read 29◦C. The NanoSight NS500 instrument
(Malvern Instruments Ltd. United Kingdom)
equipped with 405 nm laser was used. The
shutter and gain were adjusted manually and
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the NTA 2.3 (build 0025) software was applied
to capture the data as well as for the initial and
FTLA analysis.
EVs: blood donors. Samples from 3
healthy donors (coded further as P1, P2 and
P3) were used for this study. The samples has
been collected in the conjunction with our pre-
vious study on diabetics.55
Ethics. Bioethical Committee at Jagiel-
lonian University Medical College (JUMC) ac-
cepted all project’s protocols and forms, in-
cluding an information for patients form and
a consent form for participation in a research
study. The permission No. KBET/206/B/2013
is valid until 31st of December 2017.
Blood collection and platelet poor
plasma (PPP) preparation. All blood sam-
ples were drawn at the same time of the day
(between 08:00 and 10:00 am) with venipunc-
ture with > 21-gauge needle in the antecubital
vein following the application of a light tourni-
quet. Citrate blood was centrifuged twice at
2500 g for 15 min to obtain PPP. The plasma
samples were aliquoted and frozen at −80◦C
until further analysis. Before measurements
samples were thawed in a 37◦C water bath and
vortexed for 30 s.
Nanoparticle Tracking Analysis (NTA)
of plasma EVs. To avoid EVs aggregation,
all samples were diluted 100x in HEPES buffer
(10 mM Hepes/NaOH, 140 mM NaCl, 2.5 mM
CaCl2, pH 7.4). The NTA measurement was
performed with a NanoSight NS500 instrument
(Malvern Instruments Ltd, United Kingdom),
equipped with a sample chamber with a 405-
nm laser. The assay was performed at room
temperature 23.3± 0.1◦C. For each donor (P1-
P3) the measurements has been carried out 3
times. The samples were measured for 30s with
the manual shutter and gain adjustments in ad-
vanced settings. The NTA 2.3 Build 0025 soft-
ware was used for capturing of the data as well
as their preliminary and FTLA analysis.
Atomic Force Microscopy (AFM) anal-
ysis of plasma EVs. Poly-L-Lysine Slides
from Thermo Scientific (cat no J2800AMNZ)
were previously cleaved into 1 × 1cm plates,
rinsed both sides with distilled water and
cleansed by compressed air. Samples with EVs
were spread on glass slide and incubated for
1 hour in a humid chamber at room temper-
ature. Then slides were rinsed three times by
gently dipping in PBS (pH=7.4) and fixed in
2.5% glutaraldehyde in PBS for 30 minutes
at room temperature. After that, slides were
rinsed and analyzed by means of the AFM
technique. To determine the size distribution
of EVs, 20 × 20µm topographical images of
the samples were performed by Atomic Force
Microscopy - Nanoscope IIIa Multimode-SPM
(Veeco Instruments, Santa Barbara, CA, USA)
in contact mode. AFM images were recorded
in liquid (PBS) using fluid chamber and imag-
ing conditions included a 0.4 Hz scan rate, 256
points collected per line (pixel resolution). As a
probe, non-conductive pyramidal silicon nitride
tip (MLCT, Bruker) with a resonance frequency
10-20 kHz, nominal spring constant 0.01 N/m
and with a radius 100 nm was used. The topo-
graphical analysis of AFM images was carried
out using SPIP software version 6.5.2 (Image
Metrology A/S, Horsholm, Denmark). In this
software the Particle and Pore Analysis mode
was used to asses the EVs diameters. An exem-
plary image is shown in Fig. 1D and E. Image
features that were brighter (higher) than the
background were recognized as particles, while
the darker (lower) were identified as pores. The
detection threshold was set to 0.2 nm. The al-
gorithm identifies the area occupied by a par-
ticle and calculates the diameter of a disc with
the same area. This results is provided as an
EV’s diameter. Finally, the "Post processing"
was applied to classify EVs and the size distri-
bution histograms were prepared. Because the
resolution of AFM images performed in contact
mode depends on the radius and shape of the
tip (the tip convolution effect) and the tip used
in this study was relatively wide, we also de-
cided to recalculate the size of observed parti-
cles basing on correction method from Engel et
al.56
NTA data analysis
In the preliminary stage of analysis the NTA
software identifies the trajectories of observed
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particles and this raw data are available to the
user (alltracks files). Each trajectory is given as
a sequence of positions ~ri = (xi, yi) (in pixels)
on the consecutive frames indexed by i, cap-
tured by the camera. Thanks to the frame-rate
and calibration parameter provided by the soft-
ware it is possible to recalculate these data into
the actual physical units, i.e. nanometers and
seconds. NTA software is also able to distin-
guish the valid trajectories from the artefacts on
the basis of combined length and scattered light
intensity criteria. These trajectories are labeled
as included in the distribution in the output .csv
files. We restrict our analysis solely to these tra-
jectories and obtain the size distributions with
FTLA algorithm for further comparison. How-
ever, the NanoSight software gives us no con-
trol over the truncation of the trajectories and
drift treatment. Since our goal is to explicate
the difference between the Stokes-Einstein and
sub-diffusive models, we decided to perform the
MSD analysis on our own, maintaining the full
control over the data processing.
Our first goal is to determine the MSD func-
tion individually, for each trajectory. In the
first step of our analysis we introduce the in-
crements :
∆~ri(n) = ~ri+n − ~ri (5)
where ∆~ri(n) = (∆xi(n),∆yi(n)) and calculate
their average value:
< ∆~rn >=
1
N − n
N−n∑
i=1
(~ri+n − ~ri) (6)
N is the maximal number of frames on which a
particular molecule is recognized. Having found
the increments, we can calculate the MSD(n),
which reads:
MSD(n) =
1
N − n
N−n∑
i=1
(∆~ri(n)− < ∆~rn >)2
(7)
One should note that < ∆~rn > is also the mea-
sure of the average drift, so our definition re-
moves the influence of a flow along a trajectory.
In the Fig. 2A, we present the log-log plots of
MSD for three exemplary trajectories rescaled
to the actual physical units, i.e. nanometers
and seconds. These plots show several features
which are representative for our data. In gen-
eral, MSD consists of an initial period of the
linear growth on the log-log plot up to the lo-
cal maximum, followed by the interval of de-
crease and strong fluctuations. Most of the free
diffusion models, normal or sub-diffusion, can-
not describe the decrease in MSD, which usu-
ally indicates the presence of boundaries in the
system.45 One possible exception is the scaled
Brownian motion,49,50 which has a tendency to
form a local maximum in MSD, but even in
this case the effect is most pronounced in the
confinement. Thus, we conclude that the post-
maximum behavior is induced by the bound-
aries. For this reason, we must propose the
criteria to exclude it from the further analysis
based on the free diffusion models.
The features we just described are most rep-
resentative for the long (N > 9) trajecto-
ries. Unfortunately, it is well known that while
NTA measures a massive number of trajecto-
ries, there is no control over their length and,
usually, only a mere 10− 15% of them has the
length of N ≥ 5. This is particularly sever
in the EVs samples, in which the number of
trajectories is generally low. Due to the poor
statistics, the shortest trajectories have very
noisy MSD plots,57 which might significantly
deviate from what we described in the previ-
ous section. Additionally, the minimal trajec-
tory length can also significantly broaden the
diameter distribution.31,57 In our case we face
the same problem, but, in addition, we want
to analyze only those trajectories for which the
initial interval of MSD at least vaguely resem-
ble the free-diffusion behavior. This decreases
the number of trajectories even further. Thus,
for the purpose of our study, a trajectory is
accepted if its first three MSD points satisfy
MSD(1) < MSD(2) < MSD(3). This ensures
the existence of a minimal, strictly growing se-
quence. This also means that we use trajecto-
ries of N = 4 at least, which is still close to
the N = 5, recommended by Gardiner. For
donors P1, P2 and P3 the NanoSight software
has admitted respectively 919, 679 and 366 tra-
jectories of which 73%, 62% and 58% has been
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accepted according to our criterion. The afore-
mentioned problems are incomparably less se-
vere for the PS beads, for which NTA provided
usually between 1500 and 6000 relevant trajec-
tories of which 60-80% passed our criteria.
We also had to decide on how many points
of an individual MSD sequence are accounted
for the free-diffusion behavior, i.e. we had to
choose the truncation time T . Since we ex-
pect to encounter a local maximum in MSD,
we propose that T is equal to the first n vi-
olating MSD(n + 2) > MSD(n). This con-
dition can detect the systematic decrease in
MSD, which usually occurs after the local max-
imum. However, it also allows some acciden-
tal detours from the strictly growing character
of MSD (e.g. MSD(n + 1) < MSD(n) while
MSD(n + 2) > MSD(n)). The random vari-
ability of MSD must be expected, especially for
short trajectories, since the sample size from
which an individual value of MSD(n) is calcu-
lated reads N−n.57 This number is usually low
(especially for EVs) and decreases with subse-
quent n.
Having proposed the criteria of data selection
and truncation, we address the central issue of
this letter, which is the sub-diffusive dynamics
of EVs. All the selected trajectories were fitted
with the three following models:
MSD(n) = 4D1t+ C2 (8)
MSD(n) = 4Dαtα + C2 (9)
MSD(n) = 4
D1
v
ln(1 + vt) + C2 (10)
where the additional constant C2 accounts
for the localization noise as advocated by
Berglund.38 In Fig. 2A the exemplary fits ob-
tained with all the three models are shown
for weak and strongly sub-diffusive trajectories.
While for normal diffusion they perform com-
parably well, it is evident that for strong sub-
diffusion the linear model visibly deviates from
the data. While the localization noise is able to
partially remedy the quality of fits, it is still in-
sufficient, leading to the underestimated value
of D1, and, in turn, to the overestimated d. It
should be denoted that the sub-diffusive models
predict extremely low level of the localization
Figure 3: Anomalous exponent α in EVs sam-
ples: A: The histogram of α resulting from
the fitting of all accepted MSD data (see text)
with the power-law model. For each donor the
histogram has a maximum near α ' 0.7, in-
dicating the sub-diffusive behaviour. B: The
histogram of α obtained only for long (N >
50) trajectories. The maximum shifts towards
α ' 0.8. C: The joint histogram of exponent
γ resulting from fitting the average increments
< ∆xn > and < ∆yn > with the power law
model ∝ tγ. For all donors the distributions
have distinct peaks at γ ' 1 and γ ' 0.
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Table 1: The summary for anomalous exponent α. Abbreviations: EV - biological samples (extra-
cellular vesicles), PSW - polystyrene beads measured in Warsaw, PSK - polystyrene beads measured
in Krakow, C0 = 1% - initial concentration of sample solution, d - the certified diameter of a bead,
Nall - number of all accepted trajectories with length N ≥ 4, < α > - mean anomalous exponent
for all accepted trajectories, SD - standard deviation of < α >, NN>50 - number of accepted tra-
jectories longer than N = 50, < α >N>50 anomalous exponent calculated only for long trajectories,
SDN>50 - standard deviation of < α >N>50.
Id. C0 × 103 d[nm] Nall < α > SD NN>50 < α >N>50 SDN>50
EV - - 673 0.71 0.22 80 0.77 0.13
EV - - 420 0.71 0.24 50 0.81 0.16
EV - - 212 0.73 0.26 22 0.75 0.14
PSW 8 200 1872 0.74 0.20 437 0.80 0.16
PSW 5 453 1861 0.73 0.20 611 0.80 0.16
PSK 1 203 6807 0.69 0.22 566 0.80 0.16
PSK 10 203 4141 0.73 0.21 1054 0.81 0.17
PSK 1 453 1201 0.70 0.24 376 0.81 0.16
PSK 2 453 1670 0.71 0.21 610 0.80 0.16
PSK 5 453 537 0.74 0.19 268 0.80 0.16
noise.
The power-low model provides a conventional
test for anomalous diffusion. Fig. 3 and Fig.
4 show the histograms of the anomalous ex-
ponents α for EVs and PS beads, respectively.
The numerical results are also summarized in
the Table 1. In general, the distributions of
α calculated for all the accepted trajectories
(Fig. 3A and Fig. 4A), have a mono-peaked
shape with a maximum at < α >' 0.69− 0.74
and the standard deviation of approximately
0.19−0.26. This is common for all samples, i.e.
both PS beads and EVs, which shows the ubiq-
uity of the sub-diffusive behavior in NTA. How-
ever, this data include a huge number of short
trajectories with low predictive power,57 so to
minimized their influence we also plot the same
distributions, but only for the long (N > 50)
trajectories (Fig. 3B and Fig. 4B). While this
slightly shifts < α > to 0.75-0.81, the pres-
ence of sub-diffusion clearly persists. Further
increase in the minimal length of admitted tra-
jectories do not lead to a significant growth in
< α >. The experiments on the bigger beads
also suggest that there is a dependence between
< α > and concentration, i.e. as the dilution
grows by 5 times, < α > increases from 0.7 to
0.74 (see Table 1). This is in agreement with
our conjecture that the sub-diffusion is at least
partially caused by the crowding in a sample,
though the effect is rather weak.
The drift of particles was also analyzed. The
mean increments < ∆xn > and < ∆yn > (see
Fig. 2B) were fitted with the power law model
∝ tγ to test their linearity. In Fig. 3C and Fig.
4C the histograms of γ are shown. A distinct
peak at γ ' 1 indicate that, indeed, the drift
was approximately constant during the obser-
vation. The additional peak at γ = 0 was asso-
ciated with the particles experiencing no flow,
i.e. < ∆~rn >= 0. Since the majority of parti-
cles were carried by an approximately constant
drift, it is possible that they were systematically
conveyed into the denser regions, in agreement
with the assumptions of our logarithmic model.
Another step is to compare the efficiency of
size prediction between the normal diffusion
model, logarithmic sub-diffusion and FTLA al-
gorithm. As explained before, the power-law
model cannot be used for this purpose. The
mono-disperse solutions of PS beads with 203
nm and 453 nm diameters and at several differ-
ent concentrations were used as the test sam-
ples. In this paragraph we will refer to Warsaw
measurements as PSW and to experiments in
Krakow as PSK . The size histograms obtained
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Table 2: Size determination in the NTA and AFM measurements of EVs and PS beads of different
nominal size d and at different dilutions (dil.). The NTA data were analysed with the normal
diffusion model, sub-diffusion model and the FTLA algorithm. For AFM the mean size < d > was
calculated for both: entire dataset (column all) and for the particles with d ≥ 50nm (for direct
comparison with optical methods). The table summarizes < d >, standard deviation SD of d and
the position of the distribution maximum, dmax. All parameters were determined by fitting the
H(d) histograms (see Fig. 5 and 6) with the log-normal function (except for FTLA, which was
provided by the NanoSight software).
dil. < d > ± SD[nm] dmax[nm]
Id. × d NTA AFM NTA AFM
103 [nm] lin dif. sub-dif. FTLA d ≥ 50 all lin. diff sub-diff. FTLA
P1 - - 400±361 223±293 180±78 101±73 74±65 253 123 - 10
P2 - - 285±341 155±263 159±66 91±61 66±54 117 54 - 13
P3 - - 278±263 143±189 130±57 90±56 67±51 129 65 - 16
PSW 7 203 375±188 200±133 202±47 - - 254 140 199 -
PSW 5 453 598±200 364±162 450±86 - - 527 299 459 -
PSK 1 203 367±272 200±158 180±25 - - 250 127 185 -
PSK 10 203 354±479 192±137 185±19 - - 242 138 185 -
PSK 1 453 541±209 323±190 307±112 - - 473 237 385 -
PSK 2 453 539±207 338±191 348±82 - - 455 244 395 -
PSK 5 453 589±200 348±174 367±72 - - 504 293 395 -
for each sample are shown in the Fig. 5 and the
numerical results are summarized in Tab. 2. In
general, the distributions of diameters obtained
with the normal and logarithmic diffusion mod-
els are significantly asymmetric and can be ef-
ficiently fitted with the log-normal function.
Thus, one can consider the maximum and the
average of this distribution as the two possi-
ble measures of the particle size. On the other
hand, FTLA usually predicts the distribution
dominated by a single, mostly symmetric peak.
Let us consider the 203 nm beads first (Fig. 5A,
C and D). FTLA recovers this size almost per-
fectly (202 nm) for PSW and with 91% accuracy
(180 and 185 nm, depending on the concentra-
tion) for PSK . Conversely, the normal diffu-
sion model performs very poorly in both series,
predicting the mean size < d > which is twice
over-sized. The maximum of these distributions
is also shifted by '+25% in comparison to the
actual size. Similarly, the maximum of the log-
arithmic sub-diffusive model indicates the size
which is underestimated by 30-40%. However,
there is a remarkable agreement between the
expected size and < d > in the sub-diffusive
model. For PSW sub-diffusive model indicates
200 nm (98% accuracy) and for PSK it predicts
200 and 192 nm. These last two results are even
more accurate than the FTLA predictions. The
situation is much different for the bigger par-
ticles, with 453 nm diameter. FTLA works al-
most perfectly (Fig. 5B) in PSW measurements,
predicting 450 nm. However, in PSK series the
artefacts appear, decreasing < d > to 307-367
nm. If the position of the main peak is used,
the prediction improves to 385-395 nm. This
difference in FTLA performance between PSW
and PSK is astonishing, as the measurement
conditions and sample concentrations in both
cases are comparable. However, two different
versions of NanoSight software are involved in
the analysis, which might be the reason. The
sub-diffusive model proved less accurate than
FTLA, resulting in < d >= 323−348 nm. Sur-
prisingly, the best estimate is provided by the
normal diffusion model, when the maximum of
the distribution is considered. In this case the
error is lower than 11%. In general, these re-
sults strongly suggest that the diffusion model
applied to the NTA data should be chosen ac-
cording to the expected particle diameter, as,
apparently, the accuracy of methods changes
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Figure 4: Anomalous exponent α in the samples
of polystyrene beads. PSW - beads measured
in Warsaw, PSK - beads measured in Krakow,
dil. - sample dilution. A: The histogram of α
calculated for all accepted trajectories B: The
histogram of α for long (N > 50) trajectories.
C: See caption of Fig. 3C.
with the particle size. Nevertheless, < d > ob-
tained from the logarithmic sub-diffusion model
proves to be a very accurate measure for the
smaller particles.
As the final test, we applied the normal
diffusion model, logarithmic sub-diffusion and
FTLA to predict the < d > of EVs. To corrob-
orate this analysis, the samples were also exam-
ined with AFM, which provided the size distri-
bution measured by a direct imaging method.
The results for patients P1, P2 and P3 are plot-
ted in the Fig. 6 and the numerical results are
summarized in the Table 2. The size distribu-
tion obtained with AFM is an asymmetric and
mono-peaked function with < d > equal 74, 66
and 67 nm, depending on the sample. Rejecting
the particles with d < 50nm shifts this averages
to 101, 91 and 90 nm, respectively. Let us recall
that, according to our discussion in the intro-
ductory section, the factor of discrepancy be-
tween NTA and AFM reads approximately 1.5-
2.5. Using this value and the AFM data one
can estimate to expected EVs size in NTA to
be roughly equal 150-250nm. This is precisely
the size range in which the sub-diffusive model
is reliable. Indeed, the sub-diffusive model re-
sults in a d histogram whose general shape is
similar to that of the AFM distribution, with
< d >=223, 155 and 143 nm. For P2 and P3
these results neatly fall into the expected range
of discrepancy, while for P1 the difference is by
the factor of ' 3.0, which is still close to our
expectations. On the other hand, the normal
diffusion model leads to a distribution with an
appropriate shape, but predicts < d > which is
4.0-5.5 times greater than < d > from AFM.
Finally, FTLA provides < d > which is compa-
rable to the sub-diffusive results, but the shape
of the distribution is much different. In partic-
ular, FTLA predicts a few maxima of a similar
height that weakly coincide with the structure
of the normal diffusion distribution. Suppos-
edly, this is the manifestation of the problems
with FTLA in the highly poly-disperse samples,
i.e. it tries to map the actual size distribution
on a limited number of peaks. However, these
peaks do not seem to be present in the AFM
data.
Summarizing the experimental part, we have
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Figure 5: Histograms of diameter d for PS beads at different dilutions (dil.), measured with NTA.
Each panel represents the size distribution obtained with the normal diffusion model (red solid
line), logarithmic sub-diffusion (black solid line) and with FTLA algorithm (green solid). Dashed
lines show the log-normal fits applied to the data. Distributions are normalized to have the same
height at the maximum. Vertical lines indicate the position of < d >. PSW , PSK - measurements
carried out, respectively, in Warsaw and Krakow.
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Figure 6: The histograms of EVs diameter d
for three donors (A - P1,B - P2, C - P3) ob-
tained for 3 different models. Shaded black
solid line - the logarithmic sub-diffusive model,
red solid line - the normal (linear) diffusion
model, green line - FTLA algorithm. For com-
parison, the size distribution measured with
AFM (blue dashed line), for the same samples,
are shown. The vertical lines indicate the mean
value for each distribution. Histograms are nor-
malized to have the same height at the maxi-
mum.
shown that the sub-diffusive behavior occurs in
both artificial and biological samples and at a
range of concentrations. The diffusion model
applied to the MSD data proves to have a crit-
ical impact on the particles size measured with
NTA. The experiments were performed on two
different instruments, thus we can suspect that
the issue is not inherent to a specific experimen-
tal setup. The method of data selection and
the logarithmic sub-diffusive model which we
propose seem to be acceptable tools to improve
the analysis of NTA data in the biological con-
text. We have shown that for the small particles
(d ' 200nm) the sub-diffusive predictions are
on par with the state-of-the-art FTLA meth-
ods. However, our model does not introduce the
spurious manipulation of data that can cause
artefacts in the poly-disperse samples. Never-
theless, the idea behind FTLA is sound and this
approach might be improved in the future. Es-
pecially, combining the FTLA-type corrections
with the theory of sub-diffusion might lead to
a significant progress in NTA data processing
for the biological applications. We have also il-
lustrated the problem of discrepancy between
AFM and NTA size prediction for EVs. Our
results confirm that this difference exists and it
can be minimized only by applying the analysis
methods beyond the normal diffusion models.
Summary
NTA is a technique of huge potential, but its
broad application to the biological research is
still in development and requires the clarifica-
tion of many ambiguities. In this article we
analysed the problem of anomalous diffusion
affecting NTA measurements in both artificial
and biological poly-disperse systems. We pro-
posed the protocol of data processing and selec-
tion that allows us to stay in agreement with the
requirements of the free-diffusion model. We
also introduced a simple model of sub-diffusion
that can be ready-applied to retrieve the EVs
size distributions. The application of the sub-
diffusion models leads to the results compara-
ble with FTLA approach, but is more reliable in
the biological samples. It should be emphasized
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that our protocol and model can be applied in
the NTA study of any poly-disperse system pro-
vided that the sub-diffusion is observed in the
MSD data. The notorious discrepancy between
NTA and AFM results was also attributed to
the several well-recognized effects. Finally, our
approach opens a way for further development
of the NTA method.
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